LiveWire Ergogenics, Inc.
LVVV · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | 15.2% | -30.5% | – |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | 93.5% | 92.5% | 94.8% |
| EBITDA | – | $0 | $0 | $0 |
| % Margin | – | 93.3% | 111.7% | 112% |
| Net Income | – | -$0 | $0 | $0 |
| % Margin | – | -20.7% | 48.7% | 47.4% |
| EPS Diluted | – | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | $0 | $0 |
| Capital Expenditures | – | – | -$0 | $0 |
| Free Cash Flow | – | – | $0 | $0 |